IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-022-28762-2.html
   My bibliography  Save this article

A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders

Author

Listed:
  • Francesca Tucci

    (IRCCS San Raffaele Scientific Institute
    IRCCS San Raffaele Scientific Institute)

  • Stefania Galimberti

    (University of Milano — Bicocca)

  • Luigi Naldini

    (IRCCS San Raffaele Scientific Institute
    Vita-Salute San Raffaele University)

  • Maria Grazia Valsecchi

    (University of Milano — Bicocca)

  • Alessandro Aiuti

    (IRCCS San Raffaele Scientific Institute
    IRCCS San Raffaele Scientific Institute
    Vita-Salute San Raffaele University)

Abstract

Ex-vivo gene therapy (GT) with hematopoietic stem and progenitor cells (HSPCs) engineered with integrating vectors is a promising treatment for monogenic diseases, but lack of centralized databases is hampering an overall outcomes assessment. Here we aim to provide a comprehensive assessment of the short and long term safety of HSPC-GT from trials using different vector platforms. We review systematically the literature on HSPC-GT to describe survival, genotoxicity and engraftment of gene corrected cells. From 1995 to 2020, 55 trials for 14 diseases met inclusion criteria and 406 patients with primary immunodeficiencies (55.2%), metabolic diseases (17.0%), haemoglobinopathies (24.4%) and bone marrow failures (3.4%) were treated with gammaretroviral vector (γRV) (29.1%), self-inactivating γRV (2.2%) or lentiviral vectors (LV) (68.7%). The pooled overall incidence rate of death is 0.9 per 100 person-years of observation (PYO) (95% CI = 0.37–2.17). There are 21 genotoxic events out of 1504.02 PYO, which occurred in γRV trials (0.99 events per 100 PYO, 95% CI = 0.18–5.43) for primary immunodeficiencies. Pooled rate of engraftment is 86.7% (95% CI = 67.1–95.5%) for γRV and 98.7% (95% CI = 94.5–99.7%) for LV HSPC-GT (p = 0.005). Our analyses show stable reconstitution of haematopoiesis in most recipients with superior engraftment and safer profile in patients receiving LV-transduced HSPCs.

Suggested Citation

  • Francesca Tucci & Stefania Galimberti & Luigi Naldini & Maria Grazia Valsecchi & Alessandro Aiuti, 2022. "A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-28762-2
    DOI: 10.1038/s41467-022-28762-2
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-022-28762-2
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-022-28762-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Aneal Khan & Dwayne L. Barber & Ju Huang & C. Anthony Rupar & Jack W. Rip & Christiane Auray-Blais & Michel Boutin & Pamela O’Hoski & Kristy Gargulak & William M. McKillop & Graeme Fraser & Syed Wasim, 2021. "Lentivirus-mediated gene therapy for Fabry disease," Nature Communications, Nature, vol. 12(1), pages 1-9, December.
    2. Marina Cavazzana-Calvo & Emmanuel Payen & Olivier Negre & Gary Wang & Kathleen Hehir & Floriane Fusil & Julian Down & Maria Denaro & Troy Brady & Karen Westerman & Resy Cavallesco & Beatrix Gillet-Leg, 2010. "Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia," Nature, Nature, vol. 467(7313), pages 318-322, September.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Jianli Tao & Daniel E. Bauer & Roberto Chiarle, 2023. "Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing," Nature Communications, Nature, vol. 14(1), pages 1-16, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Suk See Ravin & Siyuan Liu & Colin L. Sweeney & Julie Brault & Narda Whiting-Theobald & Michelle Ma & Taylor Liu & Uimook Choi & Janet Lee & Sandra Anaya O’Brien & Priscilla Quackenbush & Tyra Estwick, 2022. "Lentivector cryptic splicing mediates increase in CD34+ clones expressing truncated HMGA2 in human X-linked severe combined immunodeficiency," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    2. Sebastian Wagner & Christoph Baldow & Andrea Calabria & Laura Rudilosso & Pierangela Gallina & Eugenio Montini & Daniela Cesana & Ingmar Glauche, 2022. "Clonal reconstruction from co-occurrence of vector integration sites accurately quantifies expanding clones in vivo," Nature Communications, Nature, vol. 13(1), pages 1-12, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-28762-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.